Silver Book Fact

New antibacterial agents between 1983 and 2012

Fact image

Total number of new antibacterial agents is in decline

Spellberg, Brad, Robert Guidos, David Gilbert, John Bradley, Helen W. Boucher, W. Michael Scheld, John G. Bartlett, John Edwards Jr., and the Infectious Diseases Society of America. The Epidemic of Antibiotic-Resistant Infections: A call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(2): 155-64. http://cid.oxfordjournals.org/content/46/2/155.full

Reference

Title
The Epidemic of Antibiotic-Resistant Infections: A call to action for the medical community from the Infectious Diseases Society of America
Publication
Clin Infect Dis
Publication Date
2008
Authors
Spellberg, Brad, Robert Guidos, David Gilbert, John Bradley, Helen W. Boucher, W. Michael Scheld, John G. Bartlett, John Edwards Jr., and the Infectious Diseases Society of America
Volume & Issue
Volume 46, Issue 2
Pages
155-64
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Negative value of antibiotics to drug companies
    The value of an antibiotic to a drug company is negative $50 million- compared to the positive value of $1 billion for a new musculoskeletal drug.  
  • Only a 20% reduction in drug-resistant infections would save $3.2 – $5.2 billion each year
    A 20% reduction in drug-resistant infections would save between 5.7 and 11.3 million additional hospital days and between $3.2 and $5.2 billion in healthcare costs, each year.  
  • An antibiotic stewardship program saved $17 million over 8 years
    An antibiotic stewardship program saved a total of $17 million over 8 years, with antibiotic costs rising $1 million in the first year after discontinuation.  
  • Pre-surgery antibiotic use reduces 6-day mortality by 50% in elderly
    Effective pre-surgery antibiotic use can reduce 60-day mortality in the elderly by 50%.  
  • Reduction of central-line infections saved ~ 1,800 lives and $280 million
    Standardization of best practice interventions reduced central line-associated blood stream infections and saved an estimated 1,800 lives and $280 million.